A study of patients with sarcoidosis treated with methotrexate showed that serum levels of angiotensin-converting enzyme (ACE) and soluble IL-2 receptor (sIL-2R) were reduced after 6 months of treatment and correlated with increased lung function [31]. Here, ACE is linked to sarcoidosis.